Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study-Reference-Cited by-同舟云学术

Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study

Published:2018-01-11 Issue:4 Volume:34 Page:689-699
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Reed Kenneth¹,Collaku Agron²,Moreira Sebastian¹

Affiliation:

1. Clinical Development and Medical Affairs, GlaxoSmithKline Consumer Healthcare, Parsippany, NJ, USA;

2. Biostatistics, GlaxoSmithKline Consumer Healthcare, Parsippany, NJ, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1417245

Reference29 articles.

1. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

2. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

3. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

4. National Institute for Health and Care Excellence. Osteoarthritis: care and management. Available at: https://www.nice.org.uk/guidance/cg177/resources/osteoarthritis-care-and-management-35109757272517 [Last accessed 19 October 2017]

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of Osteoarthritis of the knee – Secondary publication;Journal of Orthopaedic Science;2024-08

2. Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis;BioMed Research International;2020-11-04

3. Pharmacological Management of Osteoarthritis With a Focus on Symptomatic Slow-Acting Drugs;JCR: Journal of Clinical Rheumatology;2020-07-27

4. Study on the importance of medical treatment and physical methods in recovering patients with knee osteoarthritis;Balneo Research Journal;2019-05-20